News & Events

Events

WCBP

Jan 23-25
Washington, DC

OTx Xchange

Feb 28
Manchester Grand Hyatt San Diego, CA

AACR

April 5-10
San Diego, CA

BEBPA HCP

May 14-16
College Park, MD

ADLM

July 30-Aug 1
Chicago, IL

BPS

Aug 19-22
Boston, MA

OTS

Oct 6-9
Montreal, Quebec, Canada

SfN

Oct 5-9
Chicago, IL

MEDICA

Nov 11-14
Messe Dusseldorf Dusseldorf, Germany

News

OCTOBER 25, 2024
Abzyme Therapeutics' pH-Dependent Anti-CD3 Antibody Secures Key Patent
Abzyme Therapeutics LLC, a Rockland-affiliated biotechnology company, has reached a significant milestone in its pursuit to develop innovative antibody-based therapies.
AUGUST 22, 2024
The Jackson Laboratory Expands Partnership with Rockland and antibodies-online to Exclusively Offer Highly Characterized FcRn Antibodies for the Assessment of Therapeutic Drugs
The Jackson Laboratory Expands Partnership with Rockland and antibodies-online to Exclusively Offer Highly Characterized FcRn Antibodies for the Assessment of Therapeutic Drugs.
APRIL 16, 2024
Rockland, antibodies-online, and The Jackson Laboratory Partner to Exclusively Offer Innovative Genome Editing Tools to Researchers Worldwide
The Jackson Laboratory partners with Rockland and antibodies-online to provide genomic tools for global immuno-oncology research, diagnostics, and therapeutics development.
JANUARY 11, 2024
Rockland Launches Impurity Detection Kit for Accurate Measurement of Nuclease Across a Spectrum of Therapeutic Manufacturing Methods
The AccuSignal Nuclease ELISA Kit is designed to detect endonuclease to evaluate manufacturing processes for biological therapeutics, gene therapy vectors, vaccine preparations, and more.
OCTOBER 17, 2023
Rockland Launches Novel Analytical Tools to Assess Drug Delivery Revolutionizing Oligonucleotide Therapeutic Development
The first and only panel of specialty reagents designed to detect PS modifications independent of sequence, format, or location, streamlining candidate triage for unparalleled cost and time savings in early-stage non-clinical and pre-clinical discovery assessment of...
FEBRUARY 1, 2023
Rockland Launches Early Access Program for ModDetect™ Anti-PS Panel
Rockland, a pioneer in life science solutions, is excited to announce the initiation of the Early Access Program for its ModDetect™ Anti-PS Monoclonal Antibody Panel.
NOVEMBER 10, 2022
Rockland Immunochemicals, Inc. and Cytiva Life Sciences to launch PrismA ELISA Kit
In partnership with Cytiva Life Sciences, Rockland is announcing the newest addition to the portfolio - the PrismA ELISA kit. This new kit is designed to reduce the complexity in process-related impurity analytical assay development.
FEBRUARY 22, 2022
Rockland Immunochemicals, Inc. collaborates with Jefferson Institute for Bioprocessing to offer complete bioprocessing solutions
Rockland Immunochemicals, Inc. (Rockland) and the Jefferson Institute for Bioprocessing (JIB) announced today that an agreement has been signed under which both entities are able to utilize one another's strengths to provide complete and scalable bioprocessing solutio...
Load More